In vivo colocalization of antigen and CpG within dendritic cells is associated with the efficacy of cancer immunotherapy

Stefan Nierkens, Martijn H. Den Brok, Roger P.M. Sutmuller, Oliver M. Grauer, Erik Bennink, Mary E. Morgan, Carl G. Figdor, Theo J.M. Ruers, Gosse J. Adema

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

50 Citaten (Scopus)

Samenvatting

Immunostimulatory cytidyl guanosyl (CpG) motifs are of great interest as cancer vaccine adjuvants. They act as potent inducers of Th1 responses, including the activation of cytotoxic CD8+ T lymphocytes (CTL). Whereas animal models have provided clear evidence that CpG enhances antitumor immunity, clinical trials in humans have thus far been less successful. Applying cryosurgery as an instant in situ tumor destruction technique, we now show that timing of CpG administration crucially affects colocalization of antigen and CpG within EEA-1+ and LAMP-1+ compartments within dendritic cells in vivo. Moreover, antigen/CpG colocalization is directly correlated with antigen cross-presentation, the presence of CTL, and protective antitumor immunity. Thus, failure or success of CpG as a vaccine adjuvant may depend on colocalization of antigen/CpG inside DCs and hence on the timing of CpG administration. These data might aid in the design of future immunotherapeutic strategies for cancer patients.

Originele taal-2Engels
Pagina's (van-tot)5390-5396
Aantal pagina's7
TijdschriftCancer Research
Volume68
Nummer van het tijdschrift13
DOI's
StatusGepubliceerd - 1 jul. 2008
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'In vivo colocalization of antigen and CpG within dendritic cells is associated with the efficacy of cancer immunotherapy'. Samen vormen ze een unieke vingerafdruk.

Citeer dit